Peter Heald

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli et al. · Blood · 2007 · 1.4K citations

Medicine, Dermatology, Oncology +10

Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy

Richard L. Edelson, Carole L. Berger, Francis P. Gasparro et al. · New England Journal of Medicine · 1987 · 1.2K citations

Medicine, Immunology, Oncology +10

Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

Madeleine Duvic, Kenneth B. Hymes, Peter Heald et al. · Journal of Clinical Oncology · 2001 · 704 citations

Medicine, Oncology, Pharmacology +14

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 658 citations · Full text

Medicine, Dermatology, Oncology +17

Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

Elise A. Olsen, Madeleine Duvic, Arthur E. Frankel et al. · Journal of Clinical Oncology · 2001 · 610 citations

Medicine, Oncology, Pharmacology +17